Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE; SCOT Study Investigators.
N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327.
Autologous fat transfer rescues expanded skin from expansion failure: A retrospective cohort study in Asians.
Cheng C, Fang B, Xie Y, Zhao PJ, Huang RL, Zhou SB, Gu B, Herrler T, Liu K, Li QF.
J Plast Reconstr Aesthet Surg. 2022 Mar;75(3):1094-1099. doi: 10.1016/j.bjps.2021.11.055. Epub 2021 Nov 18.
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Booth C, Sevilla J, Almarza E, Kuo CY, Zubicaray J, Terrazas D, O'Toole G, Chitty-Lopez M, Choi G, Nicoletti E, Long-Boyle J, Fernandes A, Chetty K, De Oliveira S, Banuelos C, Xu-Bayford J, Bastone AL, John-Neek P, Jackson C, Moore TB, Gilmour K, Schambach A, Rothe M, Kasbekar S, Rao GR, Patel K, Shah G, Thrasher AJ, Bueren JA, Schwartz JD, Kohn DB.
N Engl J Med. 2025 May 1;392(17):1698-1709. doi: 10.1056/NEJMoa2407376.
Autologous Skin Grafts, versus Tissue-engineered Skin Constructs: A Systematic Review and Meta-analysis.
Kianian S, Zhao K, Kaur J, Lu KW, Rathi S, Ghosh K, Rogoff H, Hays TR, Park J, Rafailovich M, Simon M, Bui DT, Khan SU, Dagum AB, Singh G.
Plast Reconstr Surg Glob Open. 2023 Jun 27;11(6):e5100. doi: 10.1097/GOX.0000000000005100. eCollection 2023 Jun.
Full-Thickness Skin Grafts.
Ramsey ML, Walker B, Marietta M, Patel BC.
2025 Mar 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
A Comparative Study of Split-Thickness Skin Graft Fixation and Uptake Using Autologous Platelet-Rich Plasma Versus Conventional Methods.
Gb D, Kotennavar M, Patil AV, Jaju PP, Rathod S, Savant MS, Ghanteppagol V, Doddannavar S, Medikonda E, Parikh S.
Cureus. 2025 May 31;17(5):e85136. doi: 10.7759/cureus.85136. eCollection 2025 May.
Epidermal Tumors Arising on Donor Sites From Autologous Skin Grafts: A Systematic Review.
Chaitidis N, Papadopoulou Z, Paraschou V, Panagiotidis M.
Cutis. 2024 Aug;114(2):E6-E12. doi: 10.12788/cutis.1079.
Autologous Skin Cell Suspension in Burn Care: A Systematic Review and Meta-analysis of Clinical Outcomes.
Daneshi K, Arellano JA, Tepe S, Liu HY, Yenikomshian HA, Gillenwater J, Hultman CS, Ziembicki JA, Egro FM.
J Burn Care Res. 2026 Jan 6;47(1):370-380. doi: 10.1093/jbcr/iraf181.
Donor MHC-specific thymus vaccination allows for immunocompatible allotransplantation.
Liu Y, Feng H, Li K, Li R, Zhang XJ, Tian Y, Fang Y, Zhou Y, Liu L, Zhang X.
Cell Res. 2025 Feb;35(2):132-144. doi: 10.1038/s41422-024-01049-5. Epub 2025 Jan 3.
Human Acellular Dermal Matrix Is a Viable Alternative to Autologous Skin Graft in Patients with Cutaneous Malignancy.
Lewis RE, Towery EA, Bhat SG, Ward AJ, Heidel RE, Bielak KM, Simpson HE, McLoughlin JM, Lewis JM.
Am Surg. 2019 Sep 1;85(9):1056-1060.
